DBD stock · ILMN stock

DBD vs ILMN · P/E 28, rev $3.75B vs rev $4.34B

Diebold Nixdorf, Incorporated (DBD) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.

Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.

Illumina Inc (ILMN) is a diagnostics & research company listed on US.

Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.

Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.

DBD currently screens at market cap $2.82B and trailing P/E 28.1. ILMN currently screens at market cap $15.84B.

Not investment advice. Open the DBD and ILMN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons